Stock Watch: J&J, GSK, Lilly Bring J.P. Morgan Cheer

But Full-Year Revenue Announcements Offset Acquisitions Buzz

 
• By Andy Smith
  
Stock Watch Image, Andy Smith
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS

More from Stock Watch

More from Earnings